Level of Natural Coagulation Inhibitors among Pregnant Women in Southwest Nigeria

Abraham Akinbola

Department of Hematology, Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Joyce Olufemi-Aworinde *

Department of Hematology, Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Kola Owonikoko

Department of Obstetrics & Gynaecology Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Afolabi Salawu

Department of Chemical Pathology, Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Taiwo Oloyede

Department of Chemical Pathology, Ladoke Akintola University of Technology Ogbomoso, Oyo State, Nigeria.

Samson Ojedokun

Department of Chemical Pathology, Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Rafiat Kareem

Department of Chemical Pathology, Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Mobolaji Agunbiade-Olu

Department of Hematology, Ladoke Akintola University of Technology/Teaching Hospital, Ogbomoso, Oyo State, Nigeria.

Ibukun Akinbola

Department of Biochemistry, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.

Hannah Olawumi

Department of Hematology, University of Ilorin and University of Ilorin Teaching Hospital, Ilorin Kwara State, Nigeria.

*Author to whom correspondence should be addressed.


Abstract

Background: The risk of venous thromboembolic events (VTE) is high during pregnancy due to both physiologic changes in pregnancy and the impact of inherited and acquired thrombophilia. Protein S (PS), Protein C (PC) and Antithrombin III (ATIII) deficiencies have been found in some pregnant women with recurrent miscarriages and sudden maternal death. This study aimed to determine the changes in the level of plasma Protein C, Protein S and Antithrombin III levels, its correlation with normal pregnancy.

Methods: The study was a comparative cross-sectional study conducted among seventy-five normal pregnant women who were selected using a simple random sampling technique with seventy-five age-matched healthy nonpregnant women. Blood samples were collected for analysis of Protein C, Protein S and Antithrombin III using the Enzyme-linked Immunosorbent assay method. A semi-structured questionnaire was used as the survey instrument and Statistical analysis of data was done using SPSS version 24.

Results:  The mean ages of the respondents were 32.6±4.6 and 34.5±6.9 years for the subjects and controls respectively. Natural coagulation inhibitors (NCI) show a gradual decrease across the trimesters of pregnancy. There was a statistical significance in the level of antithrombin III and protein S in the first trimester, p<0.05. when compared with the control of Protein S of 4.78 ± 0.65 ng/mL and Antithrombin III of 554.16 ± 54.65 ng/mL respectively.

Conclusion: It was demonstrated that there was an accompanying reduction of NCI across the trimester compared with the controls. Antithrombin III and Protein S have a significant relationship with the gestation periods. Antithrombin III decreased as pregnancy advanced while Protein S decreased significantly from the first trimester to the second trimester and was maintained at that level throughout the pregnancy.

Keywords: Natural coagulation inhibitor, pregnancy, southwest; Nigeria


How to Cite

Akinbola, Abraham, Joyce Olufemi-Aworinde, Kola Owonikoko, Afolabi Salawu, Taiwo Oloyede, Samson Ojedokun, Rafiat Kareem, Mobolaji Agunbiade-Olu, Ibukun Akinbola, and Hannah Olawumi. 2023. “Level of Natural Coagulation Inhibitors Among Pregnant Women in Southwest Nigeria”. International Journal of Research and Reports in Hematology 6 (1):29-37. https://www.journalijr2h.com/index.php/IJR2H/article/view/103.

Downloads

Download data is not yet available.

References

Hoffbrand AV. PAHM. Essential heamatology. Sixth Edit. A.V. Hoffbrand PAHM, editor. Wiley-Blackwell. 2011;345-380,413-423.

Battinelli EM, Marshall A, Connors JM. The role of thrombophilia in pregnancy. Review Article. 2013;2013:1–9.

Olutayo IM, Ajayi I. Haemostatic changes during pregnancy and puerperium in Kano, North-Western Nigeria. Journal of Hematology & Thromboembolic Diseases. 2015;03(05).

A. Victor Hoffbrand, Daniel Catovsky, Edward G.D. Tuddenham ARG. Postgraduate Haematology. 6th ed. A. Victor Hoffbrand, Daniel Catovsky, Edward G.D. Tuddenham ARG, editor. Wiley-blackwell. 2011;746–928.

Walker ID, Infirmary R. Thrombophilia in pregnancy. J Clin Pathol. 2000;53:573–80.

YHH, CLS. Thrombophilia in pregnancy: Whom to screen, when to treat. Dowden Health Media. 2007;50–64.

Kenneth Kaushanky, Marshall A. Lichtman, Ernest Beutler, Thomas J. Kipps, Uri Seligsohn JTP. Williams Haematology. Eight edit. Kenneth Kaushanky, Marshall A. Lichtman, Ernest Beutler, Thomas J. Kipps, Uri Seligsohn JTP, editor. McGraw-Hill. 2010;1721–2219.

Nwagha UT, Nwagha UI, Ibegbulam OG, Ocheni S, Okpala I. Increased Prevalence of Activated Protein C Resistance During Pregnancy may Implicate Venous Thrombo Embolic Disorders as a Common Cause of Maternal Mortality in Nigeria. Journal of Basic and Clinical Reproductive Sciences. 2012;1(1):19–24.

Avwioro GO. Prothrombin time and activated partial thromboplastin time in pregnant women in Southern Nigeria. J Appl Pharm Sci. 2013;3(April):179–81.

Dawood F. Pregnancy and Thrombophilia. J Blood Disord Transfus. 2013;4(5):1–11.

Markoff A, Bogdanova N, Samama MM. Hereditary thrombophilic risk factors for recurrent pregnancy loss. Review Article. 2012;1–7.

Asaad Mohammed AA FEMH. Molecular characterization of prothrombin G20210A gene Mutations in Pregnant Sudanese women with spontaneous recurrent abortions. Rawal Medical Journal. 2015;40:207–9.

Demir C, Dilek I. Natural coagulation inhibitors and active protein c resistance in preeclampsia. Clinics. 2010;65(11):1119–22.

Jaykaran CTB. How to calculate sample size for different study designs in medical research? Indian Journal of Psychological Medicine; 2013.

Oladosu-olayiwola O, Olawumi H, Babatunde A, Ijaiya M. Fibrinolytic proteins of normal pregnancy and pre-eclamptic patients in North West Nigeria. Afr Health Sci. 2011;18(3):576–83.

Katz D, Beilin Y. Disorders of coagulation in pregnancy. Br J Anaesth. 2015;115:75–88.

Okwesili A, Ibrahim K, Nnadi DC, Barnabas B. Fibrinogen levels among pregnant women of African Descent in Sokoto North Western Nigeria. Frontiers in Biomedical Sciences. 2016;1(September):7–11.

Ronke OY. Socio – economic characteristics of residents of. Global Journal of Human-Social Science: Sociology & Culture. 2016;16(6): 1–9.

Imoru Momodu FIB. Protein c and Antithrombin III activities in healthy Nigerian women. International Journal of Haematology Research. 2015;1(1): 20–3.

Domenico Prisco, Gabriele Cuiti MF. Hemostatic changes in normal pregnancy. Haematological Reports. 2005;1(10):1–5.